BananaIP and NASSCOM present a free master class on intellectual property for startups, entrepreneurs, and SMEs. Participants will gain essential insights on protecting and commercializing their innovations, with…
Intellepedia · 21 May 2021
Natco seeks a compulsory license for Baricitinib, while the USA backs a temporary COVID-19 vaccine patent waiver. The EU critiques the US approach, and Ericsson and Samsung resolve…
Gaurav Mishra · 10 May 2021
The Supreme Court has indefinitely extended limitation periods for legal proceedings in view of the COVID-19 situation and questioned the Government's approach to compulsory licensing of essential medicines.…
Gaurav Mishra · 2 May 2021
This post analyses World IP Day amid the COVID-19 pandemic, questioning whether intellectual property systems have supported or hindered access to vital medicines. It highlights the limited measures…
Dr. Kalyan Kankanala · 26 Apr 2021
The Delhi High Court has advised the government to consider compulsory licensing of COVID-19 treatments, reflecting the urgent need for wider access. This post also covers the global…
Gaurav Mishra · 26 Apr 2021
This post provides an analytical overview of recent patent disputes and policy developments. It discusses the Nokia-Lenovo settlement, Apple’s patent damages appeal, and new USPTO initiatives related to…
Gaurav Mishra · 19 Apr 2021
The abolition of the IPAB has shifted appellate and adjudicatory functions under the Indian Patents Act to the High Courts. This post analyses the significant legal changes, outlining…
Intellepedia · 18 Apr 2021
The Tribunals Reforms Ordinance 2021 has brought significant changes to the Patents Act, 1970, by eliminating the Appellate Board and shifting its functions to the High Court. These…
Intellepedia · 6 Apr 2021
The Tribunals Reforms Ordinance 2021 has made the IPAB and several other tribunals defunct, transferring their powers to the High Courts and Commercial Courts. This post provides a…
Gaurav Mishra · 5 Apr 2021
This post examines the latest Supreme Court directions on limitation extension, the resolution of the Monsanto-Nuziveedu patent dispute, and ongoing developments at the EPO. It also discusses European…
Gaurav Mishra · 29 Mar 2021